Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lyophilized Plasma in Patients on Warfarin
NCT01541098Phase 2Withdrawn
- Sponsor
- Tricol Biomedical
- Start
- Jan 2015
- Primary completion
- Jan 2016
- Modality
- Biologic, Plasma product
01
Overview
Phase 2, randomised trial of dried plasma in coagulopathy (2 arms), sponsored by Tricol Biomedical. Primary endpoint: Assess and Compare Adverse Events at 72 hours. Planned start Jan 2015; status: withdrawn.
02
Drugs
dried plasma
03
Conditions
coagulopathy
Beyond the preview
Go deeper on NCT01541098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01541098.